O/M items only: blood and blood products and biological materials
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- 75N98024A00139
- Awardee
-
Genscript USA Inc. UEI KVLBRRAQ6UX1
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $29,189 obligated
Award facts
- Combined order value
- $29,189 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $10,000,000.00
- Maximum order
- $25,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Health and Human Services' National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,000,000 IDV contract, which does not have a set-aside designation, covers the provision of blood and blood products, biological materials, and related services in support of biomedical research and public health initiatives.
Under this BPA, NICHD has issued two firm fixed-price call orders to Genscript. The first order, valued at $14,999, is for the supply of chemical peptide synthesis materials. The second order, worth $14,190.07, is for host cell line and strain preparation services. Both orders have periods of performance ending in 2025 and were placed against the overarching BPA contract, which has an ultimate completion date of June 30, 2026. This IDV demonstrates Genscript's role in supporting critical research and public health efforts across various civilian federal agencies, including the provision of specialized molecular biology products and services.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Supplies for peppower chemical peptide synthesis. | National Institute of Child Health and Human Development (NIH) | $14,999 | |
| Service for host cell line/strain preparation SC1663-2. | National Institute of Child Health and Human Development (NIH) | $14,190 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98024A00139?
75N98024A00139 was awarded to Genscript USA Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on June 19, 2014.
How much is contract 75N98024A00139 worth?
Orders under 75N98024A00139 have obligated $29,189. 75N98024A00139's own ceiling is $10,000,000. A single order can be worth up to $25,000.
How many orders have been placed under contract 75N98024A00139?
2 orders have been placed under 75N98024A00139, the latest on August 2, 2024.
Who can order from contract 75N98024A00139?
75N98024A00139 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV